投資評等
最後更新日期：2024/5/2
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2015/8/24 | Standpoint Research | Hold >> Buy | 68 |
| 2014/4/10 | UBS | Neutral >> Buy | $84 >> $100 |
| 2012/1/12 | Robert W. Baird | Neutral >> Outperform | $47 >> $69 |
| 2011/8/1 | Standpoint Research | Hold >> Buy | |
| 2010/2/2 | William Blair | Mkt Perform >> Outperform | |
| 2009/9/11 | Barclays Capital | Equal Weight >> Overweight | |
| 2009/8/18 | Standpoint Research | Hold >> Buy | |
| 2005/10/5 | Goldman Sachs | In-Line->Outperform | |
| 2005/6/14 | Morgan Keegan | Mkt Perform->Outperform | |
| 2005/4/1 | UBS | Neutral->Buy | |
| 2005/1/3 | Lehman Brothers | Equal-weight->Overweight | 35 |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2015/3/27 | Robert W. Baird | Outperform >> Neutral | $78 >> $72 |
| 2015/3/9 | BB&T Capital Mkts | Buy >> Hold | |
| 2011/12/5 | Standpoint Research | Buy >> Hold | |
| 2011/1/14 | Standpoint Research | Buy >> Hold | |
| 2009/5/6 | Standpoint Research | Buy Hold | |
| 2006/11/10 | Goldman Sachs | Buy Neutral | |
| 2006/4/21 | Robert W. Baird | Outperform Neutral | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2015/9/17 | UBS | Neutral | 57 |
| 2014/11/25 | RBC Capital Mkts | Outperform | 105 |
| 2012/1/19 | MKM Partners | Buy | 67 |
| 2011/10/14 | Barclays Capital | Overweight | 55 |
| 2010/9/14 | Stifel Nicolaus | Buy | 45 |
| 2010/3/11 | BB&T Capital Mkts | Buy | 39 |
| 2009/12/15 | KeyBanc Capital Mkts | Hold | |
| 2006/12/15 | Wachovia | Outperform | |
| 2006/7/13 | Prudential | Overweight | 82 |
| 2005/2/11 | UBS | Neutral | 38 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2010/4/13 | FBR Capital | Outperform | $26 >> $46 |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2012/4/20 | Barclays | Overweight | $68 >> $71 |
| 2012/1/27 | Barclays Capital | Overweight | $62 >> $68 |
| 2011/3/8 | Barclays Capital | Overweight | $62 >> $72 |
| 2011/1/28 | UBS | Buy | $58 >> $61 |
| 2011/1/28 | FBR Capital | Outperform | $57 >> $59 |
| 2011/1/11 | Barclays Capital | Overweight | $52 >> $62 |
| 2010/12/17 | Stifel Nicolaus | Buy | $51 >> $60 |
| 2010/12/10 | UBS | Buy | $50 >> $58 |
| 2010/10/22 | FBR Capital | Outperform | $46 >> $48 |
| 2010/10/22 | Barclays Capital | Overweight | $50 >> $52 |